Valuation : Brooks Laboratories Limited

Market Cap 1.95B 20.61M 17.74M 16.69M 15.25M 28.52M 28.6M 197M 76.53M 999M 77.41M 75.72M 3.22B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.96B 20.81M 17.91M 16.85M 15.39M 28.79M 28.87M 199M 77.25M 1.01B 78.14M 76.43M 3.25B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
14/08 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
17/07 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
19/06 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
30/05 Brooks Laboratories appoints Prashant Rathi as CEO RE
30/05 Brooks Laboratories names Prashant Rathi as CEO RE
30/05 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
30/05 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
07/02 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
17/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
14/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
27/12/24 Brooks Laboratories Limited Appoints Ms. Krutika Mohan Rane as Company Secretary & Compliance Officer, Effective 26 December 2024 CI
1 day+2.99%
1 week-4.63%
Current month-0.71%
1 month+8.69%
3 months+1.83%
6 months+6.91%
Current year-17.56%
1 week 64
Extreme 64
71.4
1 month 58.5
Extreme 58.5
71.4
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
163.9
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer - 01/06/2026
Chief Executive Officer 58 23/01/2002
President 57 23/08/2023
Director TitleAgeSince
Director/Board Member 62 10/09/2010
Director/Board Member 61 13/09/2011
Director/Board Member 53 23/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%-4.63%-54.60%-35.00% 20.61M
-0.89%-1.09%+20.02%+71.25% 48.26B
-1.72%-1.15%+47.28%+115.51% 40.5B
-2.01%-5.96%+10.68%+80.50% 11.83B
-0.70%-2.70%-12.22%+11.80% 11.85B
+0.57%-0.56%+26.56%+154.33% 9.36B
-1.67%-0.35%+41.04%-12.04% 7.37B
+0.08%-4.11%+22.91%+43.56% 7.5B
-0.89%-3.09%+22.42%+220.05% 7.28B
-0.16%-2.36%-42.27%+15.39% 5.19B
Average -0.44%-2.37%+8.18%+66.54% 14.92B
Weighted average by Cap. -1.06%-1.72%+23.65%+84.29%

Financials

2025 2026
Net sales 826M 8.74M 7.52M 7.08M 6.47M 12.1M 12.13M 83.65M 32.46M 424M 32.83M 32.12M 1.36B 857M 9.08M 7.81M 7.35M 6.72M 12.56M 12.6M 86.88M 33.71M 440M 34.1M 33.36M 1.42B
Net income -99.67M -1.06M -908K -855K -781K -1.46M -1.46M -10.1M -3.92M -51.14M -3.96M -3.88M -165M 246M 2.6M 2.24M 2.11M 1.93M 3.6M 3.61M 24.91M 9.67M 126M 9.78M 9.56M 406M
Net Debt 75.39M 799K 687K 646K 591K 1.1M 1.11M 7.64M 2.96M 38.68M 3M 2.93M 125M 18.44M 195K 168K 158K 144K 270K 271K 1.87M 725K 9.46M 733K 717K 30.48M
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
04/09/26 INR 66.07 +2.99% 12,920
03/09/26 INR 64.15 -1.46% 24,891
02/09/26 INR 65.10 -2.06% 23,544
01/09/26 INR 66.47 -0.11% 15,066
31/08/26 INR 66.54 -3.95% 31,613
  1. Stock Market
  2. Stocks
  3. BROOKS Stock